• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及上埃及多发性硬化症的诊断延迟及其相关因素。

Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients.

机构信息

Neuropsychiatric Department, Faculty of Medicine, Assiut University Hospital, Assiut, Egypt.

Neuropsychiatric Department, Faculty of Medicine, Aswan University Hospital, Aswan, Egypt.

出版信息

Sci Rep. 2023 Feb 8;13(1):2249. doi: 10.1038/s41598-023-28864-x.

DOI:10.1038/s41598-023-28864-x
PMID:36754987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9908930/
Abstract

The earlier the diagnosis of multiple sclerosis (MS), the sooner disease-modifying treatments can be initiated. However, significant delays still occur in developing countries. We aimed to identify factors leading to delayed diagnosis of MS in Upper Egypt. One hundred forty-two patients with remitting relapsing MS (RRMS) were recruited from 3 MS units in Upper Egypt. Detailed demographic and clinical data were collected. Neurological examination and assessment of the Disability Status Scale (EDSS) were performed. The mean age was 33.52 ± 8.96 years with 72.5% of patients were females. The mean time from symptom onset to diagnosis was 18.63 ± 27.87 months and the median was 3 months. Seventy-two patients (50.7%) achieved diagnosis within three months after the first presenting symptom (early diagnosis), while seventy patients (49.3%) had more than three months delay in diagnosis (delayed diagnosis). Patients with a delayed diagnosis frequently presented in the period before 2019 and had a significantly higher rate of initial non-motor presentation, initial non-neurological consultations, prior misdiagnoses, and a higher relapse rate. Another possible factor was delayed MRI acquisition following the initial presentation in sixty-six (46.5%) patients. Multivariable logistic regression analysis demonstrated that earlier presentation, initial non-neurological consultation, and prior misdiagnosis were independent predictors of diagnostic delay. Despite advances in MS management in Egypt, initial non-neurological consultation and previous misdiagnoses are significant factors responsible for delayed diagnosis in Upper Egypt.

摘要

多发性硬化症(MS)的诊断越早,就能越早开始采用疾病修正治疗。然而,在发展中国家,仍然存在显著的延迟。我们旨在确定导致上埃及 MS 诊断延迟的因素。从埃及上埃及的 3 个 MS 单位招募了 142 名缓解复发型 MS(RRMS)患者。收集了详细的人口统计学和临床数据。进行了神经学检查和残疾状况量表(EDSS)评估。平均年龄为 33.52±8.96 岁,其中 72.5%的患者为女性。从症状出现到诊断的平均时间为 18.63±27.87 个月,中位数为 3 个月。72 名患者(50.7%)在首次出现症状后 3 个月内获得诊断(早期诊断),而 70 名患者(49.3%)在诊断上有超过 3 个月的延迟(延迟诊断)。诊断延迟的患者经常在 2019 年之前出现,初始非运动表现、初始非神经科就诊、先前误诊和更高的复发率的发生率显著更高。另一个可能的因素是 66 名患者(46.5%)在初始表现后 MRI 采集延迟。多变量逻辑回归分析表明,更早的就诊、初始非神经科就诊和先前误诊是诊断延迟的独立预测因素。尽管埃及在 MS 管理方面取得了进展,但初始非神经科就诊和先前误诊是导致上埃及诊断延迟的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5191/9908930/7f0b18989480/41598_2023_28864_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5191/9908930/7f0b18989480/41598_2023_28864_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5191/9908930/7f0b18989480/41598_2023_28864_Fig1_HTML.jpg

相似文献

1
Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients.埃及上埃及多发性硬化症的诊断延迟及其相关因素。
Sci Rep. 2023 Feb 8;13(1):2249. doi: 10.1038/s41598-023-28864-x.
2
Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.在埃及新注册中心登记的多发性硬化症患者的临床特征。
Mult Scler Relat Disord. 2016 Nov;10:30-35. doi: 10.1016/j.msard.2016.06.013. Epub 2016 Jun 27.
3
Mitoxantrone: a review of its use in multiple sclerosis.米托蒽醌:其在多发性硬化症中的应用综述
CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010.
4
Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt.治疗满意度是改善多发性硬化症患者治疗依从性的唯一预测因素,本研究来自埃及上埃及地区。
Sci Rep. 2024 Mar 25;14(1):7027. doi: 10.1038/s41598-024-57116-9.
5
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.米托蒽醌治疗复发缓解型和快速进展型多发性硬化症:米托蒽醌治疗后十年的临床结果
Mult Scler Relat Disord. 2020 Sep;44:102330. doi: 10.1016/j.msard.2020.102330. Epub 2020 Jun 23.
6
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.继发进展型多发性硬化症诊断与管理中的方法及挑战:中东欧医疗专业人员视角
Mult Scler Relat Disord. 2021 May;50:102778. doi: 10.1016/j.msard.2021.102778. Epub 2021 Jan 28.
7
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.多发性硬化症的诊断延迟:患病率、决定因素和后果。
Mult Scler. 2023 Oct;29(11-12):1437-1451. doi: 10.1177/13524585231197076.
8
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.早期多发性硬化症中的延迟认知加工与治疗现状偏差
Mult Scler Relat Disord. 2022 Dec;68:104138. doi: 10.1016/j.msard.2022.104138. Epub 2022 Aug 20.
9
Contribution of relapse-associated worsening to overall disability accrual in patients with relapsing-onset multiple sclerosis: A mediation analysis.复发相关恶化对复发缓解型多发性硬化患者总体残疾进展的影响:中介分析。
Mult Scler Relat Disord. 2022 Mar;59:103555. doi: 10.1016/j.msard.2022.103555. Epub 2022 Jan 22.
10
Delayed diagnosis of multiple sclerosis in a low prevalence country.多发性硬化症在低流行国家的延迟诊断。
Neurol Res. 2021 Jul;43(7):521-527. doi: 10.1080/01616412.2020.1866374. Epub 2020 Dec 23.

引用本文的文献

1
Multiple sclerosis patients' journey delay in diagnosis and treatment: a multicenter study.多发性硬化症患者诊断和治疗的旅程延误:一项多中心研究。
BMC Neurol. 2025 Sep 2;25(1):377. doi: 10.1186/s12883-025-04172-x.
2
Current Practices, Challenges, and Future Directions in Multiple Sclerosis Management in Sub-Saharan Africa.撒哈拉以南非洲地区多发性硬化症管理的当前实践、挑战及未来方向
Int J MS Care. 2025 Apr 15;27(Theme):T13-T16. doi: 10.7224/1537-2073.2024-080. eCollection 2024 Dec.
3
Clinical and epidemiological characteristics of multiple sclerosis in the southern region of the Republic of Azerbaijan.

本文引用的文献

1
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018.过去十年中东地区多发性硬化症治疗方法的应用:2009-2018 年。
CNS Drugs. 2021 Oct;35(10):1097-1106. doi: 10.1007/s40263-021-00833-w. Epub 2021 Jun 23.
2
Challenges in multiple sclerosis care: Results from an international mixed-methods study.多发性硬化症护理中的挑战:一项国际混合方法研究的结果。
Mult Scler Relat Disord. 2021 May;50:102854. doi: 10.1016/j.msard.2021.102854. Epub 2021 Feb 23.
3
Delayed diagnosis of multiple sclerosis in a low prevalence country.
阿塞拜疆共和国南部地区多发性硬化症的临床和流行病学特征
Pak J Med Sci. 2025 Feb;41(2):437-442. doi: 10.12669/pjms.41.2.11373.
4
Functional and postoperative outcomes in ideal pouch-anal anastomosis in patients with parkinson disease and multiple sclerosis.帕金森病和多发性硬化症患者理想的袋肛吻合术后功能和结果。
Langenbecks Arch Surg. 2024 Oct 15;409(1):308. doi: 10.1007/s00423-024-03498-3.
5
The Clinical Nurse Practitioner's Essential Role in Early Diagnosis and Management of Multiple Sclerosis in Europe: A Consensus Report.欧洲临床护士从业者在多发性硬化症早期诊断与管理中的关键作用:一份共识报告。
Int J MS Care. 2024 Aug 5;26(Q3):208-213. doi: 10.7224/1537-2073.2023-070. eCollection 2024 May.
6
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.一项评估简化中心静脉评估用于多发性硬化症诊断的多中心试点研究。
Mult Scler. 2024 Jan;30(1):25-34. doi: 10.1177/13524585231214360. Epub 2023 Dec 13.
7
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.多发性硬化症的诊断延迟:患病率、决定因素和后果。
Mult Scler. 2023 Oct;29(11-12):1437-1451. doi: 10.1177/13524585231197076.
8
EDSS and infratentorial white matter lesion volume are considered predictors of fatigue severity in RRMS.EDSS 和小脑白质病变体积被认为是 RRMS 疲劳严重程度的预测因子。
Sci Rep. 2023 Jul 14;13(1):11404. doi: 10.1038/s41598-023-38368-3.
多发性硬化症在低流行国家的延迟诊断。
Neurol Res. 2021 Jul;43(7):521-527. doi: 10.1080/01616412.2020.1866374. Epub 2020 Dec 23.
4
Assessment of delayed diagnosis and treatment in multiple sclerosis patients during 1990-2016.评估 1990-2016 年多发性硬化症患者的延迟诊断和治疗情况。
Acta Neurol Belg. 2021 Feb;121(1):199-204. doi: 10.1007/s13760-020-01528-7. Epub 2020 Nov 12.
5
Multiple sclerosis diagnosis delay and its associated factors among Iranian patients.多发性硬化症的伊朗患者的诊断延误及其相关因素。
Clin Neurol Neurosurg. 2020 Dec;199:106278. doi: 10.1016/j.clineuro.2020.106278. Epub 2020 Oct 4.
6
Advances in oral immunomodulating therapies in relapsing multiple sclerosis.口服免疫调节疗法在复发型多发性硬化中的进展。
Lancet Neurol. 2020 Apr;19(4):336-347. doi: 10.1016/S1474-4422(19)30391-6. Epub 2020 Feb 11.
7
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region.中东和北非(MENA)地区多发性硬化症的流行病学与表型
Mult Scler J Exp Transl Clin. 2020 Jan 14;6(1):2055217319841881. doi: 10.1177/2055217319841881. eCollection 2020 Jan-Mar.
8
Multiple Sclerosis Misdiagnosis: A Persistent Problem to Solve.多发性硬化症的误诊:一个亟待解决的长期问题。
Front Neurol. 2019 May 7;10:466. doi: 10.3389/fneur.2019.00466. eCollection 2019.
9
Diagnostic Delay of Multiple Sclerosis in a Portuguese Population.葡萄牙人群中多发性硬化症的诊断延迟
Acta Med Port. 2019 Apr 30;32(4):289-294. doi: 10.20344/amp.11187.
10
Delayed diagnosis of multiple sclerosis in males: may account for and dispel common understandings of different MS 'types'.男性多发性硬化症的延迟诊断:可能解释并消除对不同类型多发性硬化症的常见误解。
Br J Gen Pract. 2019 Mar;69(680):148-149. doi: 10.3399/bjgp19X701729.